Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
article
OA: gold
CC0
⤵ 3 in-corpus citations
AI-generated summary
Dienogest suppressed endometrial polyp proliferation, with greater effect on sessile types, but did not impact inflammation markers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Administration of Dienogest prior to hysteroscopic polypectomy is empirically performed, but the physiological effects of Dienogest on endometrial polyps are unclear. We aimed to investigate the effects of Dienogest on the proliferation and inflammation of endometrial polyps. We conducted a retrospective case study on 40 menstruating women who underwent hysteroscopic polypectomy at our hospital. We collected clinical data, and the polyps were divided by morphological appearance. The specimens obtained were immunostained for Ki67 as a marker of cellar proliferation and CD138 as a marker of plasmacytes, which are a hallmark of chronic endometritis. Dienogest significantly suppressed the proliferation status of EPs because Dienogest treatment prior to the operation significantly reduced the Ki67 index (41.25 ± 16.85 vs 7.18 ± 9.82, p < 0.01). We found that sessile-type polyps showed a significantly lower Ki67 index than the pedunculated type (12.28 ± 11.12 vs 2.09 ± 2.73, p = 0.026). The presence of CD138-positive cells was more pronounced in sessile-type polyps than in pedunculated polyps ( p = 0.018). However, Dienogest treatment showed no apparent effect on inflammation status, as detected by CD138-positive cells. We revealed that Dienogest suppressed cellular proliferation, and morphological classification of endometrial polyps could be used to predict the responsiveness to Dienogest. However, Dienogest might not affect cellular inflammation.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle via openalex
- Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside via openalex
- Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
- Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review via openalex
- Endometritis: new time, new concepts via openalex
- Risk of endometrial polyps in women with endometriosis: a meta-analysis via openalex
- The Association between Endometriosis and Chronic Endometritis via openalex
- The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study via openalex
- W2515466307 via openalex
- W1996280689 via openalex
- W2625168222 via openalex
- W2753092865 via openalex
- W1984265328 via openalex
- W2902348010 via openalex
- W2912028687 via openalex
- W2912370346 via openalex
- W2915631645 via openalex
- W2921965973 via openalex
- W3010163019 via openalex
- W2020228322 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK